Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s effector cell pipeline includes multiplexed-engineered, iPSC-derived natural killer (NK) cell and T-cell product candidates, which incorporate novel synthetic controls of cell function, such as chimeric antigen receptors (CARs) to target tumor-associated antigens and are intended to deliver multiple mechanisms of therapeutic importance to patients including in combination with well-established cancer therapies. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.
View Top Employees from Fate Therapeutics IncWebsite | http://www.fatetherapeutics.com |
Ticker | FATE |
Revenue | $63.1 million |
Funding | $565.5 million |
Employees | 429 (429 on RocketReach) |
Founded | 2007 |
Address | 12278 Scripps Summit Dr, San Diego, California 92131, US |
Phone | (858) 875-1800 |
Technologies |
JavaScript,
HTML,
PHP
+60 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Stem Cells, Healthcare, Science and Engineering, Stem Cell Modulators, Health Care, Ips Cells, Therapeutics, Ipscs |
Web Rank | 1 Million |
Keywords | Cancer Treatment, Immunotherapy |
Competitors | Apellis Pharmaceuticals, Atara Biotherapeutics, Cytokinetics, HARBOUR BIOMED, Reata Pharmaceuticals, Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325414 Companies, NAICS Code 325 Companies |
Looking for a particular Fate Therapeutics Inc employee's phone or email?
The Fate Therapeutics Inc annual revenue was $63.1 million in 2024.
Edward Dulac is the CFO of Fate Therapeutics Inc.
429 people are employed at Fate Therapeutics Inc.
Fate Therapeutics Inc is based in San Diego, California.
The NAICS codes for Fate Therapeutics Inc are [32, 32541, 3254, 325414, 325].
The SIC codes for Fate Therapeutics Inc are [283, 28].